ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/08/04 | 1,303 | 1,366 | 1,302 | 1,346 | +13 | +1% | 2,247,700 |
| 2023/08/03 | 1,241 | 1,441 | 1,235 | 1,333 | +78 | +6.2% | 4,639,900 |
| 2023/08/02 | 1,281 | 1,294 | 1,248 | 1,255 | -44 | -3.4% | 841,800 |
| 2023/08/01 | 1,291 | 1,314 | 1,273 | 1,299 | +2 | +0.2% | 900,900 |
| 2023/07/31 | 1,279 | 1,312 | 1,251 | 1,297 | +78 | +6.4% | 1,615,000 |
| 2023/07/28 | 1,173 | 1,221 | 1,167 | 1,219 | +37 | +3.1% | 794,900 |
| 2023/07/27 | 1,175 | 1,189 | 1,169 | 1,182 | +1 | +0.1% | 367,700 |
| 2023/07/26 | 1,180 | 1,199 | 1,169 | 1,181 | -11 | -0.9% | 446,500 |
| 2023/07/25 | 1,190 | 1,193 | 1,166 | 1,192 | -6 | -0.5% | 833,300 |
| 2023/07/24 | 1,205 | 1,217 | 1,195 | 1,198 | -12 | -1% | 451,500 |
| 2023/07/21 | 1,200 | 1,219 | 1,189 | 1,210 | +21 | +1.8% | 565,000 |
| 2023/07/20 | 1,208 | 1,209 | 1,188 | 1,189 | -27 | -2.2% | 742,600 |
| 2023/07/19 | 1,211 | 1,223 | 1,201 | 1,216 | -1 | -0.1% | 808,500 |
| 2023/07/18 | 1,231 | 1,242 | 1,208 | 1,217 | +10 | +0.8% | 701,100 |
| 2023/07/14 | 1,240 | 1,257 | 1,203 | 1,207 | -25 | -2% | 827,700 |
| 2023/07/13 | 1,199 | 1,248 | 1,191 | 1,232 | +44 | +3.7% | 1,259,000 |
| 2023/07/12 | 1,223 | 1,232 | 1,181 | 1,188 | -37 | -3% | 1,259,800 |
| 2023/07/11 | 1,239 | 1,263 | 1,222 | 1,225 | -13 | -1.1% | 946,300 |
| 2023/07/10 | 1,260 | 1,286 | 1,232 | 1,238 | -24 | -1.9% | 1,080,800 |
| 2023/07/07 | 1,272 | 1,293 | 1,255 | 1,262 | -12 | -0.9% | 1,238,600 |
| 2023/07/06 | 1,321 | 1,322 | 1,230 | 1,274 | -54 | -4.1% | 2,736,000 |
| 2023/07/05 | 1,360 | 1,364 | 1,318 | 1,328 | -39 | -2.9% | 902,900 |
| 2023/07/04 | 1,418 | 1,442 | 1,366 | 1,367 | -51 | -3.6% | 1,133,800 |
| 2023/07/03 | 1,400 | 1,438 | 1,386 | 1,418 | +18 | +1.3% | 916,700 |
| 2023/06/30 | 1,377 | 1,412 | 1,340 | 1,400 | +23 | +1.7% | 1,196,900 |
| 2023/06/29 | 1,390 | 1,435 | 1,367 | 1,377 | +12 | +0.9% | 2,294,600 |
| 2023/06/28 | 1,465 | 1,474 | 1,328 | 1,365 | -92 | -6.3% | 3,593,200 |
| 2023/06/27 | 1,460 | 1,513 | 1,454 | 1,457 | -43 | -2.9% | 1,560,300 |
| 2023/06/26 | 1,475 | 1,528 | 1,469 | 1,500 | -8 | -0.5% | 1,453,900 |
| 2023/06/23 | 1,632 | 1,633 | 1,491 | 1,508 | -114 | -7% | 3,495,100 |
| 2023/06/22 | 1,586 | 1,694 | 1,581 | 1,622 | +20 | +1.2% | 3,739,600 |
| 2023/06/21 | 1,660 | 1,675 | 1,570 | 1,602 | -41 | -2.5% | 2,864,900 |
| 2023/06/20 | 1,520 | 1,685 | 1,456 | 1,643 | +83 | +5.3% | 6,597,000 |
| 2023/06/19 | 1,552 | 1,657 | 1,530 | 1,560 | +163 | +11.7% | 8,662,900 |
| 2023/06/16 | 1,397 | 1,397 | 1,397 | 1,397 | +300 | +27.3% | 193,800 |
| 2023/06/15 | 1,115 | 1,115 | 1,091 | 1,097 | -21 | -1.9% | 568,700 |
| 2023/06/14 | 1,131 | 1,135 | 1,116 | 1,118 | -10 | -0.9% | 314,700 |
| 2023/06/13 | 1,147 | 1,148 | 1,124 | 1,128 | -8 | -0.7% | 349,200 |
| 2023/06/12 | 1,098 | 1,140 | 1,095 | 1,136 | +37 | +3.4% | 550,900 |
| 2023/06/09 | 1,111 | 1,114 | 1,096 | 1,099 | -3 | -0.3% | 329,900 |
| 2023/06/08 | 1,104 | 1,112 | 1,096 | 1,102 | -1 | -0.1% | 252,200 |
| 2023/06/07 | 1,114 | 1,120 | 1,095 | 1,103 | -8 | -0.7% | 291,800 |
| 2023/06/06 | 1,103 | 1,119 | 1,096 | 1,111 | -3 | -0.3% | 279,300 |
| 2023/06/05 | 1,110 | 1,120 | 1,095 | 1,114 | +17 | +1.5% | 370,900 |
| 2023/06/02 | 1,125 | 1,130 | 1,095 | 1,097 | -26 | -2.3% | 433,700 |
| 2023/06/01 | 1,097 | 1,123 | 1,086 | 1,123 | +35 | +3.2% | 536,200 |
| 2023/05/31 | 1,095 | 1,096 | 1,081 | 1,088 | -10 | -0.9% | 330,500 |
| 2023/05/30 | 1,103 | 1,105 | 1,073 | 1,098 | -1 | -0.1% | 331,500 |
| 2023/05/29 | 1,091 | 1,114 | 1,076 | 1,099 | +20 | +1.9% | 388,200 |
| 2023/05/26 | 1,094 | 1,102 | 1,076 | 1,079 | -17 | -1.6% | 371,500 |
201～
250
件表示中 / 3467件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 220,300円 | +52.1% | +23.3% | 0.00% | 15.60倍 | 3.26倍 |
|
創薬ベンチャー。米国で人工骨も。中国の特発性肺線維症薬で高シェア、米中に研究開発機能 |
| 持田薬 | 303,000円 | +3.0% | +27.5% | 2.64% | 19.18倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 171,500円 | +3.2% | +4.5% | 3.03% | 19.71倍 | 0.75倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 鳥居薬 | 378,500円 | +7.3% | +16.8% | 3.17% | 22.64倍 | 0.89倍 |
|
ＪＴ傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗ＨＩＶ薬の販売権喪失が直撃 |
| ゼリア新薬 | 198,700円 | +9.6% | +17.5% | 2.32% | 11.23倍 | 1.10倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
